tiprankstipranks
OSE Immunotherapeutics SA (FR:OSE)
:OSE
France Market
OSE
OSE Immunotherapeutics SA
RESEARCH TOOLSreports
Want to see FR:OSE full AI Analyst Report?

OSE Immunotherapeutics SA (OSE) Financial Statements

14 Followers

OSE Immunotherapeutics SA Financial Overview

OSE Immunotherapeutics SA's market cap is currently €81.17M. The company's EPS TTM is €-1.69; its P/E ratio is -2.13; OSE Immunotherapeutics SA is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 2.62M€ 69.88M€ 2.23M€ 18.30M€ 26.31M
Gross Profit€ 2.62M€ 69.88M€ 2.23M€ 18.30M€ 26.31M
Operating Income€ -48.06M€ 43.73M€ -22.99M€ -18.48M€ -16.63M
EBITDA€ -44.81M€ 41.20M€ -17.50M€ -13.11M€ -13.72M
Net Income€ -37.70M€ 37.45M€ -23.00M€ -17.76M€ -16.85M
Balance Sheet
Cash & Short-Term Investments€ 22.65M€ 16.75M€ 18.67M€ 25.62M€ 33.58M
Total Assets€ 78.44M€ 123.96M€ 82.05M€ 91.67M€ 101.52M
Total Debt€ 35.38M€ 46.13M€ 45.80M€ 44.79M€ 37.13M
Net Debt€ 17.82M€ 29.39M€ 27.13M€ 19.17M€ 3.55M
Total Liabilities€ 51.10M€ 60.15M€ 59.08M€ 59.12M€ 53.99M
Stockholders' Equity€ 27.34M€ 63.81M€ 22.82M€ 32.55M€ 47.89M
Cash Flow
Free Cash Flow€ -34.13M€ 48.36M€ -20.00M€ -18.53M€ -10.39M
Operating Cash Flow€ -34.03M€ 48.44M€ -19.76M€ -18.25M€ -9.92M
Investing Cash Flow€ 41.35M€ -46.91M€ -507.00K€ 26.00K€ -827.00K
Financing Cash Flow€ -6.51M€ -3.46M€ 13.32M€ 10.27M€ 14.96M
Currency in EUR

OSE Immunotherapeutics SA Earnings and Revenue History

Income Statement >

OSE Immunotherapeutics SA Debt to Assets

Balance Sheet >

OSE Immunotherapeutics SA Cash Flow

Cash Flow >

OSE Immunotherapeutics SA Forecast EPS vs Actual EPS

Earnings >